Cargando…
Hematopoietic Cell Transplantation for Older Patients with MDS
The incidence of myeloid malignancies, including myelodysplastic syndromes (MDS) increases with age. While several therapeutic modalities have been developed, for most of these patients the only treatment with curative potential is allogeneic hematopoietic cell transplantation (HCT). The development...
Autores principales: | Shadman, Mazyar, Deeg, H. Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165501/ https://www.ncbi.nlm.nih.gov/pubmed/25237469 http://dx.doi.org/10.4084/MJHID.2014.056 |
Ejemplares similares
-
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
por: Pourhassan, H, et al.
Publicado: (2016) -
Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
por: Yang, Guancui, et al.
Publicado: (2022) -
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
por: Trowbridge, Jennifer J., et al.
Publicado: (2021) -
Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy
por: Zimmerman, Zachary, et al.
Publicado: (2011) -
Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients
por: Langemeijer, Saskia MC, et al.
Publicado: (2016)